Literature DB >> 8458639

Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi.

P B Petray1, M E Rottenberg, G Bertot, R S Corral, A Diaz, A Orn, S Grinstein.   

Abstract

We studied the effect of in vivo administration of anti-gamma-IFN and anti-IL-4 monoclonal antibodies on the resistance of mice against myotropic and reticulotropic strains of Trypanosoma cruzi. Anti-gamma-IFN treatment augmented the susceptibility of mice when infected with the reticulotropic RA and Tulahuén strains of T. cruzi but did not alter the course of infection with the myotropic CA-I strain of the parasite. In vivo administration of anti-IL-4 enhanced the resistance of mice when infected with either Tulahuén or RA strains but did not affect the course of parasitemia when infected with CA-I. The possible biological relevance of these observations is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458639     DOI: 10.1016/0165-2478(93)90151-q

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  14 in total

1.  B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.

Authors:  Fabiola Cardillo; Edilberto Postol; Jorge Nihei; Luiz S Aroeira; Auro Nomizo; José Mengel
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

Review 2.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

3.  Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.

Authors:  C R Marinho; M R D'Império Lima; M G Grisotto; J M Alvarez
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity.

Authors:  S Frosch; D Küntzlin; B Fleischer
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Heterogeneity in the synthesis of alpha-macroglobulins in outbred Swiss albino mice acutely infected with Trypanosoma cruzi.

Authors:  M R Luz; F van Leuven; T C de Araújo-Jorge
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

6.  Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi.

Authors:  I A Abrahamsohn; A P da Silva; R L Coffman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice.

Authors:  E C Lima; I Garcia; M H Vicentelli; P Vassalli; P Minoprio
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

8.  Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei.

Authors:  M E Rottenberg; M Bakhiet; T Olsson; K Kristensson; T Mak; H Wigzell; A Orn
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Negative tissue parasitism in mice injected with a noninfective clone of Trypanosoma cruzi.

Authors:  M T Lima; H L Lenzi; C R Gattass
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

10.  Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice.

Authors:  Kara L Cummings; Rick L Tarleton
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.